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Abstract 
Background: Long‑lasting insecticidal nets (LLIN), improved diagnosis and artemisinin‑based combination therapy 
(ACT) have reduced malaria prevalence in Papua New Guinea since 2008. Yet, national incidence trends are inconclu‑
sive due to confounding effects of the scale‑up of rapid diagnostic tests, and inconsistencies in routine reporting.
Methods: Malaria trends and their association with LLIN and ACT roll‑out between 2010 and 2014 in seven sentinel 
health facilities were analysed. The analysis included 35,329 fever patients. Intervention effects were estimated using 
regression models.
Results: Malaria incidence initially ranged from 20 to 115/1000 population; subsequent trends varied by site. Overall, 
LLIN distributions had a cumulative effect, reducing the number of malaria cases with each round (incidence rate ratio 
ranging from 0.12 to 0.53 in five sites). No significant reduction was associated with ACT introduction. Plasmodium 
falciparum remained the dominant parasite in all sentinel health facilities. Resurgence occurred in one site in which a 
shift to early and outdoor biting of anophelines had previously been documented.
Conclusions: LLINs, but not ACT, were associated with reductions of malaria cases in a range of settings, but sustain‑
ability of the gains appear to depend on local factors. Malaria programmes covering diverse transmission settings 
such as Papua New Guinea must consider local heterogeneity when choosing interventions and ensure continuous 
monitoring of trends.
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Background
Malaria in Papua New Guinea (PNG) was described 
by Koch in 1900 [1, 2] and to date malaria transmis-
sion remains endemic in PNG especially in areas below 
1400  m altitude [3, 4]. Over the last century, the epi-
demiology of malaria in PNG has been influenced by 
control and elimination efforts [2, 4–6]. In the 1950s 
to 1980s, PNG had joined efforts of the Global Malaria 
Eradication Programme with spraying of dichlorodiphe-
nyltrichloroethane (DDT) and mass drug administration 
(primarily chloroquine) [6]. The programme concluded 
before elimination was achieved and malaria resurged in 
the 1990s [2, 4]. In 2004, control efforts were re-intensi-
fied with funding from the Global Fund to Fight AIDS, 
Tuberculosis and Malaria to the PNG national malaria 
control programme (NMCP). Since then, the NMCP has 
promoted: (1) the country-wide free distribution of long-
lasting insecticidal nets (LLIN); (2) behaviour change 
campaigns; and, (3) the scaling-up of parasitological 
diagnosis by rapid diagnostic test (RDT) or microscopy, 
together with the introduction of artemisinin-based 
combination therapy (ACT), specifically artemether-
lumefantrine [7].
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Since this last scale-up, the malaria burden in PNG 
has steadily decreased as reflected in declining preva-
lence of infection [8], incidence [9] and transmission 
[10]. However, malaria control efforts are intrinsically 
affected by the great environmental and socio-cultural 
diversity across the country, including a major moun-
tain range over the length of the main island, dense 
rainforests in the highlands, lowland and coastal areas, 
and large wetlands surrounding major rivers [2]. This 
diversity has influenced human population distribu-
tion, human behaviour and mosquito ecology. All this, 
and the presence of four human pathogenic malaria 
parasites (Plasmodium falciparum, Plasmodium vivax, 
Plasmodium malariae, Plasmodium ovale), results in a 
complex malaria epidemiology with heterogeneous lev-
els of endemicity [2, 3, 5, 11].
While changes in malaria prevalence have been con-
sistently investigated since 2008 [8], national trends 
in malaria incidence are inconclusive and difficult to 
interpret due to confounding effects of the scale-up of 
RDTs, changes in health facility reporting forms, and 
inconsistencies in routine reporting [7].
This study aimed to estimate malaria trends over time 
(2010–2014) in seven sentinel health facilities (SHF) and 
assess the effect of repeated household-level distributions 
of LLINs and the introduction of ACT in distinct epide-
miological settings across PNG.
Methods
Study design
A health facility based longitudinal study established sur-
veillance of malaria cases, severity of symptoms, net use and 
parasite species composition in seven purposively selected 
sentinel health facilities from 2010 to 2014 (Fig.  1). Inter-
vention roll-out was recorded for each site. In four sites, a 
baseline population census was conducted in the catchment 
areas of the SHF. In addition, satellite data was extracted for 
each site and for the duration of the surveillance period to 
complement clinical data with environmental data.
Study sites
SHFs were functioning health centres and one sub-centre 
(Sausi), accessible by road or air, with a catchment pop-
ulation of at least 5000 people, that regularly reported 
Fig. 1 Location of sentinel health facilities in Papua New Guinea (red crosses). Dark lines indicate regional boundaries
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malaria cases. The catchment area defined by the local 
authorities was adopted for the surveillance. Surveillance 
activities were established as part of the continuous inde-
pendent evaluation of the NMCP [4, 7]. Seven SHFs were 
selected; two each from Southern, Momase and Islands 
regions, and one from the Highlands region where the 
malaria burden is lower due to higher altitudes [3]. A 
description of each site is provided in Additional file 1.
Data collection
Clinical data at the sentinel health facilities
The surveillance period in each SHF and the timing of 
LLIN distribution rounds and introduction of ACT as 
first-line treatment are provided in Additional file 2.
All outpatient cases attending a SHF were routinely 
screened for a history of self- reported fever in the pre-
vious 3 days (‘fever case’). Study-related procedures were 
performed by registered nursing officers or community 
health workers (“study nurses”) trained in the proper per-
formance of capillary blood sample collection, the use 
and reading of RDT test kits according to the manufac-
turer’s guidelines, the disposal of bio-hazardous waste, 
and the recording or results according to the study pro-
tocol. The study nurses were based full-time at the facil-
ity and collected a capillary blood sample by finger-prick 
from all consenting fever patients for: (1) point-of-care 
diagnosis of malaria by RDT; (2) thick and thin blood 
smear for malaria diagnosis by light microscopy; and, (3) 
measurement of haemoglobin (Hb) concentration. All 
RDT-positive cases were considered ‘malaria cases’ in 
this analysis. Severe malaria was defined as RDT-positive 
cases presenting with at least one of the following danger 
signs: impaired consciousness (including coma or convul-
sions), difficulty breathing, or severe anaemia (Hb < 8 g/
dl, or < 7 g/dl for children under 5 years old and pregnant 
women). Demographic details of the patients (age, sex, 
pregnancy status) and self-reported mosquito net use the 
previous night were recorded on paper case report forms 
alongside selected clinical indicators, including axillary 
temperature, Hb measurement and RDT results. Patients 
were then transferred to a health facility clinician for 
further examination. The final diagnosis as determined 
by the health facility clinician and prescribed treatment 
were recorded in the same case report form. The study 
team ensured availability of RDTs during the surveillance 
period.
RDTs (ICT Malaria Combo HRP2/aldolase, ICT Diag-
nostics, South Africa) were used following manufactur-
er’s guidelines. A sub-sample was further examined by 
light microscopy at the Papua New Guinea Institute of 
Medical Research (PNGIMR) to identify the Plasmodium 
species (Additional file  3). Microscopy slides were fixed 
with methanol (thin smear), stained with Giemsa (thin 
and thick smear) and read independently by two micros-
copists. Discordant reads were confirmed with a third 
read by a senior microscopist (World Health Organiza-
tion level 1 or 2). The number of parasites was counted 
for 200 white blood cells and a slide was declared nega-
tive after reading a minimum of 200 thick film fields. Hb 
concentration was measured using a HemoCue Hb 201+ 
Analyser (HemoCue AB, Sweden) and axillary tempera-
ture with a digital thermometer.
Demographic composition
A population census was conducted in the catchment 
areas of East Cape, Karimui, Sausi and Lemakot at the 
beginning of the surveillance period. The available fund-
ing was insufficient to conduct a baseline census in the 
three remaining SHFs. For the census village leaders 
assisted in the identification of households and enumera-
tion of household members. The variables captured for 
each household included: household size, and age and 
sex of each household member. The annual population 
growth rate of 3.1% was obtained from the National Sta-
tistics Office [12].
Environmental data
Rainfall (product 3B43) and Enhanced Vegetation Index 
(EVI; products MOD13Q1 and MOD13A3) data were 
extracted from remote-sensing databases by the Tropi-
cal Rainfall Measuring Mission (TRMM) and the Earth 
Observing System (EOS) respectively. Rainfall data were 
accessed using the Mirador system in the NASA Godd-
ard Earth Sciences Data and Information Services Center 
(GES DISC) website [13–15]. EVI data were accessed 
using the NASA Earth Data Search website [16]. In 
addition the annual occurrence of the El Niño/La Niña 
phenomena was extracted from the NASA Earth Obser-
vatory [17]. Key environmental variables are available in 
Additional file 4.
Data analysis
Statistical data analysis was conducted using Stata/IC 
v.13.1 (Stata Corp LP., College Station, USA). Monthly 
data were graphically displayed to visualize trends in the 
numbers of fevers and malaria cases by SHF. Monthly 
accumulated rainfall in mm (product 3B43), was included 
as proxy of site-specific seasonality [13–15]. Missing 
periods in surveillance data reflect temporary unavail-
ability of study nurses due to leave or staff change and 
were not related to particular times of the year.
The annual proportions of RDT-positive fever cases 
(RDT positivity) were calculated with 95% exact confi-
dence interval (CI). The Plasmodium species composi-
tion was estimated from the light microscopy results. 
Details are provided in Additional file 3.
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For the four sites with available census data, malaria 
incidence (all cases with a positive RDT) and ‘severe 
malaria’ incidence were calculated per 1000 population 
per year. Population denominators were adjusted for 
an annual growth rate of 3.1%.
The association between the roll-out of interventions 
(each of the three rounds of LLIN distribution and of 
the introduction of ACT as first-line treatment for test-
confirmed malaria) and the number of malaria cases was 
assessed using regression models. The number of cases 
was used as the outcome since denominators were only 
available in four sites. To investigate the effect of LLIN 
distribution rounds, malaria cases were disaggregated by 
age groups for each LLIN distribution round. Regression 
models were used to assess the effect of both interven-
tions simultaneously in the seven sites. The LLIN distri-
bution variable had three different values, one for each 
period between LLIN distributions. The ACT variable 
was binary, with value zero before the introduction of 
ACT and value one thereafter. In preliminary analyses, 
time since the intervention was included as a variable. 
However, due to the limited number of observations for 
each site and the need for simplicity for interpretation 
these variables were not included in the final model.
Negative binomial regression was used to estimate 
the effect of the interventions on the monthly aggre-
gate number of malaria cases. Fixed effects were 
included for the interventions and further covariates. 
Separate models were applied for each SHF after first 
establishing that the effects of the LLIN rounds were 
significantly different between sites using interactions 
terms. Due to convergence limitations, Poisson regres-
sion was used for the model with interactions.
The use of environmental variables such as rainfall (with 
and without time-lag) and EVI was explored. Initially rain-
fall was included in the model as a monthly mean per day 
and alternatively as accumulated monthly aggregate. Intro-
duction of these variables in the model was explored with 
and without time-lags (1 month and 2 months). EVI vari-
ables were similarly explored in the model. The monthly 
averages of two different EVI products were introduced 
in the model with and without time-lag. These variables 
were later omitted from the model due to poor predictive 
ability. Finally, the estimates were adjusted for El Niño and 
La Niña annual occurrence. El Niño/La Niña variable was 
introduced in the model as a categorical variable with 3 
possible values for annual occurrence (El Niño in 2010, La 
Niña in 2011 and 2012 and none in 2013 and 2014).
Results
During the surveillance period, a total of 35,329 fever 
cases were recorded across all SHFs. RDT results were 
available for 98% (range: 94–99%) of all cases (Table 1). 
The pooled RDT positivity was 32%. Site-specific RDT 
positivity ranged from 4% in Balimo to 49% in East 
Cape.
The pattern of fever and malaria cases varied over the 
surveillance period and between SHFs (Figs. 2, 3, 4 and 
5). All sites displayed monthly variations but there was 
no clear relationship with rainfall patterns. The number 
of fever and malaria cases decreased over the surveil-
lance period in all sites except in Dreikikir and Sausi, 
where after an initial decrease an increase was noted 
in 2014. Malaria cases initially increased in Lema-
kot (2012), but decreased steadily thereafter. Annual 
RDT positivity decreased steadily over the surveillance 
period in most sites but fluctuations were observed 
especially in sites with low numbers of cases. A sub-
stantial increase in RDT positivity in Lemakot (from 
35 to 68%) in the year 2012 with proportional increase 
in P. vivax and a spike of cases in women aged 15–20 
(Additional file 6) suggests a local epidemic.   
Plasmodium falciparum was the predominant species 
in all sites and all years even though species composi-
tion fluctuated over time and differed between sites. 
Balimo was the only SHF in which no infections with P. 
vivax were detected. Proportional increases of P. vivax 
were observed in Lemakot (2012) and Sausi (2014) at 
a time when the total number of malaria cases also 
increased (Figs.  2 and 5). Over the entire surveillance 
period, only 0.2% of malaria cases were diagnosed with 
P. malariae and 0.02% with P. ovale.
The annual incidence rate of malaria calculated for four 
sites ranged from 1/1000 population in Karimui in 2014 
Table 1 Number of  fever cases and  rapid diagnostic test 
result by sentinel health facility
RDT rapid diagnostic test, CI confidence interval
Health facility Fever cases
N
RDT positive N
(%, 95% CI)
RDT not done N
(%, 95% CI)
Balimo 1596 57
(4, 3–5)
100
(6, 5–8)
East Cape 7311 3601
(49, 48–50)
137
(2, 1.6–2.2)
Karimui 3166 583
(18, 17–20)
34
(1, 0.7–1.5)
Dreikikir 3869 876
(23, 21–24)
27
(0.7, 0.5–1.0)
Sausi 6450 1654
(26, 25–27)
238
(4, 3–4)
Arawa 3183 439
(14, 13–15)
61
(2, 1–2)
Lemakot 9754 4111
(42, 41–43)
77
(0.7, 0.6–1.0)
Total 35,329 11,321
(32, 32–33)
674
(2, 1.8–2.1)
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Fig. 2 Malaria cases in Southern Region (Balimo and East Cape) sites. Left of each panel: monthly number of fever cases RDT negative (bright blue) 
and RDT positive (dark blue); cumulative monthly rainfall (grey line); timing of LLIN distribution and introduction of ACT (vertical dashed lines). 
Missing data is indicated by light grey shaded background. Right of each panel: annual RDT positivity (bar total) by species: P. falciparum (orange), P. 
vivax (green), mixed infections (yellow), no species data available (white)
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Fig. 3 Malaria cases in Highlands Region (Karimui) site. Left of each 
panel: monthly number of fever cases RDT negative (bright blue) and 
RDT positive (dark blue); cumulative monthly rainfall (grey line); timing 
of LLIN distribution and introduction of ACT (vertical dashed lines). 
Missing data is indicated by light grey shaded background. Right of 
each panel: annual RDT positivity (bar total) by species: P. falciparum 
(orange), P. vivax (green), mixed infections (yellow), no species data 
available (white)
to 187/1000 in Lemakot in the peak year 2012. Incidence 
rates were highest in East Cape and Lemakot, except in 
2014, when Sausi exhibited significantly higher incidence 
than the other sites. Severe malaria incidence ranged 
from 0.4/1000 in Karimui in 2014 to 28/1000 in Lemakot 
in 2011. In general, severe malaria incidence was high-
est in 2011 and lowest in 2014, except in Sausi, where a 
2.6-fold increase was observed after 2013 (Table 2). The 
annual proportion of malaria cases being severe malaria 
ranged from 4% in East Cape in 2013 to 67% in Karimui 
in 2014. In Balimo and Arawa all severe malaria cases 
were attributed to P. falciparum. The greatest propor-
tion of severe malaria with P. vivax (39%) was observed in 
Karimui in 2011 but by 2014 all cases were P. falciparum 
(Additional file  5). Since the number of severe malaria 
cases is very low in Karimui some of the variations might 
be attributed to chance fluctuations.
The effect of the LLIN distribution on age-specific 
malaria incidence was assessed in the four sites with 
available age-specific population data. Malaria inci-
dence was reduced with each LLIN distribution round 
in East Cape, Karimui and Lemakot. The greatest 
decrease was observed in the age groups 0–4 years and 
5–9  years (Fig.  6). Incidence in Sausi initially decreased 
but increased again after the third distribution. When 
disaggregated by age group and gender, females in some 
sites and age groups appeared to have a higher incidence 
of malaria, e.g., in Lemakot (age group 15–19) and Sausi 
(age group 30–39), and differences in incidence rates 
between distribution rounds did not always affect males 
and females equally (Additional file 6).
Self-reported LLIN use increased in general with each 
distribution round and then gradually decreased over 
the subsequent years. Net use was highest in Sausi (90–
100%), Balimo (95–100%) and Dreikikir (77–86%) and 
lowest in the two Islands sites of Arawa (21–69%) and 
Lemakot (41–48%), confirming data of the 2010/2011 
national malaria indicators survey (Additional file 7) [18]. 
The treatment of malaria patients with ACT was consist-
ently high (> 80% each year) after the introduction of the 
drug in Balimo, East Cape, Dreikikir, Sausi, and Lemakot. 
The previous treatment combination of amodiaquine or 
◂
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Fig. 4 Malaria cases in Momase Region (Dreikikir and Sausi) sites. Left of each panel: monthly number of fever cases RDT negative (bright blue) and 
RDT positive (dark blue); cumulative monthly rainfall (grey line); timing of LLIN distribution and introduction of ACT (vertical dashed lines). Missing 
data is indicated by light grey shaded background. Right of each panel: annual RDT positivity (bar total) by species: P. falciparum (orange), P. vivax 
(green), mixed infections (yellow), no species data available (white)
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Fig. 5 Malaria cases in Islands Region (Arawa and Lemakot) sites. Left of each panel: monthly number of fever cases RDT negative (bright blue) and 
RDT positive (dark blue); cumulative monthly rainfall (grey line); timing of LLIN distribution and introduction of ACT (vertical dashed lines). Missing 
data is indicated by light grey shaded background. Right of each panel: annual RDT positivity (bar total) by species: P. falciparum (orange), P. vivax 
(green), mixed infections (yellow), no species data available (white)
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chloroquine plus sulfadoxine–pyrimethamine (SP) was 
phased out over the same period. The opposite trend was 
observed in Karimui, where ACT was gradually substi-
tuted by the previous treatment regimen 1 year after its 
introduction and in Arawa, where in 2014, most patients 
were treated neither with the old, nor with the new regi-
men (Additional file 8). Annually, less than 1.3% of nega-
tive cases were treated with ACT in all SHFs. Information 
on the use of primaquine is available in the Additional 
file 9.
Due to significant heterogeneity in the estimated 
effects of LLIN distribution rounds on the number of 
malaria cases between sites (p < 0.001, interaction test), 
the effects of interventions were estimated for each SHF 
individually and adjusted for El Niño/La Niña years. In 
general, subsequent distribution of LLINs led to cumula-
tive reductions in the number of malaria cases (Table 3). 
The greatest reductions were in settings where the num-
ber of cases was the lowest (Balimo, Karimui, Arawa) 
rather than in places with high net use but high case load. 
In Sausi, where an earlier study had suggested significant 
impact of the first LLIN distribution [9], the second dis-
tribution reduced the number of cases by 57% (95% CI 
11–79%) but a two-fold increase was observed after the 
third distribution.
The change of treatment from amodiaquine or chlo-
roquine plus SP to ACT did not appear to significantly 
affect the number of malaria cases except in Drekikir and 
Lemakot where an increase was observed.
Discussion
Malaria surveillance in SHFs revealed varying trends 
in the number of malaria cases and the magnitude of 
their association with control interventions between 
2010 and 2014. In general, reductions in the number of 
malaria cases were observed with each of three rounds of 
household-level LLIN distribution while no substantial 
reductions followed the change of treatment to ACT. The 
number of malaria cases was found to increase in one site 
after the third distribution round. The findings disclose a 
substantial sub-national heterogeneity in the epidemiol-
ogy and control of malaria in PNG.
After the first large-scale LLIN distribution in PNG, 
data from six sentinel surveillance sites indicated a drop 
in the average monthly malaria incidence rate from 
13/1000 population to 2/1000 (incidence rate ratio = 0.12; 
95% CI 0.09–0.17) and reductions in prevalence and 
transmission confirming significant short-term effect 
of LLIN in the absence of ACT [9]. Previous modelling 
studies suggested that the effect of LLIN may fade over 
time as acquired immunity in the population is reduced, 
particularly in areas with a high pre-intervention ento-
mological inoculation rate [19]. The situation observed 
in Dreikikir and Sausi is consistent with this predic-
tion. On the other hand, considering LLIN coverage was 
consistently high (self-reported use 90–100% in Sausi, 
77–89% in Dreikikir, Additional file 5) [9], other factors 
such as aging of nets may fuel ongoing transmission. In 
the absence of insecticide resistance, early and outdoor 
biting of Anopheles mosquitoes has been identified as a 
threat to the effectiveness of LLINs. Entomological stud-
ies in Sausi have described a shift in mosquito biting to 
earlier hours following the first LLIN distribution (the 
peak exposure time to infectious bites shifted from later 
than 9  p.m. in 2008 to between 6 and 7 p.m. in 2011) 
resulting in decreased protection against mosquito bites 
[10, 20].
Gender differences, or anomalies in the age-specific 
incidence rates, (e.g., higher incidence rates in females 
age 15–19 in Lemakot; Additional file  6) might suggest 
Table 2 Annual incidence of malaria and ‘severe malaria’ per 1000 population in four sentinel health facilities
Only sites with available census denominator data were included
CI confidence interval
Health facility 2010 2011 2012 2013 2014
N 95% CI N 95% CI N 95% CI N 95% CI N 95% CI
Malaria incidence
 East Cape 115 (107, 124) 117 (109, 125) 179 (170, 189) 141 (133,150) 47 (42, 52)
 Karimui 19 (16, 22) 34 (31, 38) 6 (4, 8) 6 (5, 8) 1 (0.2, 1)
 Sausi 20 (17, 24) 79 (72, 86) 79 (72, 87) 43 (38, 48) 79 (72, 86)
 Lemakot – – 113 (107,119) 187 (180, 194) 55 (51, 59) 19 (17, 22)
‘Severe malaria’ incidence
 East Cape 7 (5, 9) 24 (20, 28) 10 (8, 13) 6 (4, 8) 3 (2, 5)
 Karimui 2 (1, 4) 14 (12, 17) 3 (2, 4) 2 (1, 3) 0.4 (0.1, 1)
 Sausi 1 (1, 3) 18 (15, 22) 13 (10, 16) 8 (6, 10) 21 (17, 25)
 Lemakot – – 28 (25, 31) 27 (24, 30) 6 (5, 8) 4 (3, 5)
Page 10 of 13Rodriguez‑Rodriguez et al. Malar J          (2019) 18:364 
gender-specific risk. In Lemakot, the substantial increase 
in malaria cases in 2012 was disproportionately due to 
cases in teenage girls, suggesting a local outbreak. Age 
or gender-specific behaviour (e.g., evening activities, 
division of household chores) or other social or cultural 
determinants including location and quality of houses 
may result in different levels of exposure. Such factors 
have been well investigated in settings in which most of 
the transmission is limited to specific population groups 
(e.g., in Southeast Asia [21–23]). In highly diverse set-
tings such as PNG, one challenge will be to identify risk 
factors that disproportionately affect particular popula-
tion groups, and to translate such knowledge into tar-
geted control action. A mixed methods approach that 
captures behavioural patterns alongside prevalence and 
incidence data, linked with entomological investigations 
in settings with ongoing transmission, will be an impor-
tant first step.
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Fig. 6 Malaria incidence rate by age group after each LLIN distribution round in four sites. LLIN long‑lasting insecticide‑treated bed net
Table 3 Estimated effects of  each round  of  LLIN distribution and  ACT introduction on  the  number of  malaria cases 
by sentinel health facility
All estimates were adjusted for La Niña or El Niño year
IRR incidence rate ratio, CI confidence interval
Health facility 2nd vs. 1st
LLIN distribution
3rd vs. 2nd
LLIN distribution
Introduction of ACT 
IRR 95% CI IRR 95% CI IRR 95% CI
Balimo – – 1.32E−09 (0.00, –) 1.21 (0.47, 3.14)
East Cape 0.53 (0.20, 1.41) 0.34 (0.18, 0.64) 1.50 (0.79, 2.85)
Karimui 0.19 (0.06, 0.58) 0.12 (0.03, 0.43) 0.95 (0.32, 2.80)
Dreikikir 1.15 (0.54, 2.46) – – 3.95 (1.89, 8.25)
Sausi 0.43 (0.21, 0.89) 2.08 (1.16, 3.72) 1.28 (0.76, 2.16)
Arawa – – 0.15 (0.06, 0.36) 1.79 (0.57, 5.64)
Lemakot – – 0.26 (0.14, 0.50) 1.73 (1.09, 2.75)
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Most of the evidence of the impact of insecticide-
treated nets originates from African settings and is lim-
ited to the effect on P. falciparum [24]. While multiple 
studies demonstrated the effect of LLIN programmes 
on P. falciparum incidence (e.g. [25, 26]), evidence from 
settings with several Plasmodium species is scarce. 
Although it has been suggested that the impact of vec-
tor control on P. vivax may be delayed due to the para-
site’s biology, this study only found short-term transient 
increases in the proportion of P. vivax by light micros-
copy, suggesting that at intermediate to high transmis-
sion, both species are affected by vector control and 
both species may resurge. A modelling study found that 
in such areas LLINs alone could not lead to interruption 
of P. vivax transmission and additional tools are required 
to accelerate to elimination [27]. Considering the abun-
dance of low level parasitaemia, particularly in P. vivax 
infections as transmission is reduced, more sensitive 
diagnostic tools may need to be applied to monitor pro-
gress and species composition [28].
A number of field and modelling studies have shown 
a reduction in malaria cases and/or transmission after 
the introduction of ACT alone and in combination with 
LLINs [29–34]. In this study, the change in first-line treat-
ment from amodiaquine or chloroquine plus SP to ACT 
did not lead to a decrease in the number of cases. Neither 
did it result in an increase in the proportion of P. vivax 
cases despite the higher susceptibility of P. falciparum to 
artemether-lumefantrine [35] and the low consistent use 
of primaquine as radical cure of P. vivax. In general, the 
previous treatment was used widely (though not always 
strictly according to guidelines) before the introduction 
of ACT (Additional file 7) and the regimen had retained 
approximately 82% efficacy (chloroquine plus SP in 2005–
2007 [35]) limiting the increase in efficacy after ACT roll-
out to 13%. Additionally, while an efficacious drug can 
improve clinical outcomes [36] a community-wide effect 
on transmission (and hence incidence) is, among other 
factors, a function of treatment seeking and prevalence 
of asymptomatic and sub-microscopic infections. Indi-
viduals with asymptomatic infections fuel ongoing trans-
mission and do not seek treatment [8, 37, 38]. In PNG, 
only 43% of fever cases were found to have attended a 
health facility (2013/14) [39], thus the increase in efficacy 
might have been insufficient to translate into reduced 
transmission and incidence, as already demonstrated 
in an African high-transmission setting [40]. In the two 
sites in which an increase in the number of malaria cases 
was observed following the introduction of ACT, overall 
facility attendance did not suggest an availability effect 
resulting from the introduction of free intervention, as 
documented elsewhere [41, 42]. A recent study in PNG 
even suggests that the shift to test-based ACT treat-
ment may have negatively impacted treatment seeking 
and patient satisfaction, possibly related to low perceived 
quality of care provided to patients with non-malarial ill-
ness [43]. Differences in the length of post-intervention 
periods used for the regression model may have affected 
the reliability of estimates for Dreikikir as the period pre-
ceding ACT introduction was only 3 months (Additional 
file 2), most likely not enough to gain reliable estimates 
for both interventions.
Different surveillance starting points and lack of pre-
LLIN data were limitations to this study but data from 
previous surveillance activities and national prevalence 
surveys provide supporting evidence of the short-term 
effect of LLINs [4, 8, 9]. Fluctuations in treatment seek-
ing or facility attendance may have influenced inci-
dence estimates to a certain degree, but data from 
repeat national surveys suggests that the proportion 
of fever patients attending a formal health facility has 
remained largely unchanged since the first assessment 
in 2008/09 [44].
Despite previous validation and use in other set-
tings [14, 45], none of the available site-specific satellite 
weather variable (EVI: MODIS products MOD13Q1 and 
MOD13A3; and rainfall: TRMM product 3B43) could 
explain variations in malaria incidence over time which 
supports historical descriptions of an intricate and com-
plex environment driving malaria epidemiology across 
in PNG [2, 5, 8, 46, 47]. Particularly in an environment 
with high overall rainfall, weather variables may not be 
a good single predictor of malaria incidence. In contrast 
the El Niño/La Niña phenomena appeared to be a useful 
and more stable environmental predictor since it affects 
larger areas for a longer period of time than site-specific 
weather data.
Differences in pre-intervention malaria transmission 
and in the impact of interventions between sites are a 
function of the diverse social and ecological settings 
which lead to differences in vector abundance, vector 
behaviour and human–vector interaction. Multi-discipli-
nary studies on a smaller scale are required to broaden 
the understanding of malaria transmission dynamics on 
a sub-national level and identify regional factors driving 
the observed heterogeneity. Insights from such inves-
tigations should be translated into response strategies 
that take into consideration sub-national heterogeneity 
in the drivers of ongoing malaria transmission. A robust 
surveillance system reporting case incidence should be 
supported by monitoring of entomological and immuno-
logical parameters to explain differences in the impact of 
interventions.
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Conclusions
Subsequent household level distributions of LLINs had 
a cumulative effect on reducing the number of malaria 
cases in the SHFs but the magnitude of the association 
varied between sites and over time. Changing treatment 
to ACT had no apparent effect. Malaria programmes 
covering diverse transmission settings such as PNG must 
consider local heterogeneity when choosing interven-
tions and ensure continuous monitoring of trends.
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